Author Question: A patient has just purchased a 1-year supply of 28-day-cycle oral contraceptives. She tells the ... (Read 61 times)

chads108 · **on:** Jul 23, 2018

A patient has just purchased a 1-year supply of 28-day-cycle oral contraceptives. She tells the nurse she wishes she had planned things better, because she has calculated that her period will begin during her upcoming honeymoon.

What will the nurse suggest? a. She should discard the inert pills and start a new pack during the honeymoon.
b. She should discontinue the oral contra-ceptives and use an alternative form of birth control.
c. She should discuss a prescription for an extended-cycle product with her provider.
d. She should discuss DMPA (De-po-Provera) injections in addition to the OC with her provider.

Question 2

A prescriber orders ramipril Altace for an obese patient with type 2 diabetes mellitus who has developed hypertension. The nurse provides teaching before dismissing the patient home.

Which statement by the patient indicates understanding of the teaching? a. I am less likely to develop diabetic nephropathy when taking this medica-tion.
b. I should check my blood sugar more of-ten, because hyperglycemia is a side effect of this drug.
c. Taking this medication helps reduce my risk of stroke and heart attack.
d. This medication will probably prevent the development of diabetic retinopathy.

Chocorrol77 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
OC users can achieve an extended-cycle schedule by discarding the inert pills and beginning a new pack for up to four cycles. It is not necessary to discontinue OCs. Because this woman has already purchased a 1-year supply, using the 28-day-cycle product as described is appropriate. If this woman opts for a long-term product, she should discontinue the OC.

Answer to Question 2

C
Ramipril Altace is approved for reducing the risk of stroke and myocardial infarction (MI) in patients at high risk for a major cardiovascular event because they have hypertension in conjunc-tion with a history of stroke or MI or because they have diabetes. ACE inhibitors cannot be used for primary prevention of diabetic nephropathy, but they can delay the onset of overt nephropa-thy in patients who already have less advanced nephropathy. ACE inhibitors do not affect serum electrolytes or glucose. One ACE inhibitor, enalapril, can reduce the risk of diabetic retinopathy in some patients with type 1 diabetes mellitus.